您的位置：
首页
>
农业专利
>
详情页
DERIVADO DE QUINONA 2,3-DIMETOXI-5-METIL-6-(10-HIDROXIDECIL)-1,4 BENZOQUINONA PARA O TRATAMENTO DE ESCLEROSE MÚLTIPLA PRIMÁRIA PROGRESSIVA
专利权人:
SANTHERA PHARMACEUTICALS (SCHWEIZ) AG
发明人:
THOMAS MEIER,HENRY F. MCFARLAND,BIBIANA BIELEKOVA
申请号：
PT09795720
公开号：
PT2424513E
申请日:
2009.12.18
申请国别(地区):
PT
年份:
2015
代理人:
摘要：
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Kinonszármazék 2,3-dimetoxi-5-metil-6-(10-hidroxidecil)-1,4-benzokinon primer progresszív sclerosis multiplex kezeléséhez
DERIVAT KINONA-2,3-DIMETOKSI-5-METIL-6-(10-HIDROKSIDECIL)-1,4-BENZOKINON ZA LIJEÄŚENJE PRIMARNO PROGRESIVNE MULTIPLE SKLEROZE
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
Quinone derivative-2,3-dimethoxy-5-methyl-6- (10-hydroxydecyl) -1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of Primary Progressive Multiple Sclerosis
